…list screening. Clinical trials and clinical studies evaluating celecoxib, etoricoxib or rofecoxib in patients with IBD and musculoskelet…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 305 of 2459…) or to have comorbidities such as diabetes (20.8% vs 24.7%) or peripheral vascular disease (4.1% vs 4.8%). Patients who received PHECG had lower mortality…
…ification of HGS weakness and asymmetry, which may help prevent frailty progression.…
…hways to allow for the early assessment and early management of sarcopenia. The future screening tool should embed a clear process of the …
…1.38), TNFi 1.01 (0.66 to 1.54), rituximab 1.14 (0.71 to 1.84), tocilizumab 1.48 (0.92 to 2.40). LDA and remission rates were unaffected by…
…ic role for interleukin (IL)-31 signalling in driving fibrosis. Nemolizumab, a humanised monoclonal antibody targeting the IL-31 receptor a…
… hypoglycaemia and identify opportunities to reduce term infant hypoglycaemia admissions.Design Retrospective observational cohort study, the…
…his study was approved by the Institutional Review Board of the University of Yamanashi (Approval Number: CS0075). Written informed consent will be obt…
…d hypertension (168, 84%) and diabetes (113, 56.5%) followed by chronic kidney disease (CKD) (47, 24%). Self-reported non-adherence to medications (mi…
…ssential for long-term viral remission. Pegylated interferon-α (Peg-IFN-α) exhibits potent antiviral and immunomodulatory properties that…
…Objectives Iron deficiency (ID) is frequent in heart failure (HF). Among patients with HF and ID, those with impaired iron t…
… score, 14-item Hamilton Anxiety Rating Scale score and 17-item Hamilton Depression Rating Scale score, as well as responder rates (proportion with ≥25% ESS red…